Author Correction: Innate lymphoid cells in the initiation, regulation and resolution of inflammation - Scorecard - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Correction: Innate lymphoid cells in the onset, control, and resolution of inflammation

  • By

  • Gregory F. Sonnenberg

  • David Artis

  • November 10, 2026

Share

Clinical Scorecard: Correction: Innate lymphoid cells in the onset, control, and resolution of inflammation

At a Glance

CategoryDetail
ConditionInnate lymphoid cells and inflammation
Key MechanismsThe correction concerns wording about Ucp1 in the section on ILC2s and metabolic homeostasis: Ucp1 is a mitochondrial carrier protein, not a transcription factor.
Target PopulationNot specified; this is a correction notice.
Care SettingNot specified; the notice corrects terminology in a scientific article.

Key Highlights

  • The notice corrects Nature Medicine DOI 10.1038/nm.3892.
  • The article appeared online on 29 June 2015.
  • In the section “ILC2s and metabolic homeostasis,” “transcription factor Ucp1” was corrected to “mitochondrial carrier protein Ucp1.”

Guideline-Based Recommendations

Diagnosis

    Management

      Monitoring & Follow-up

        Risks

          Patient & Prescribing Data

          Not applicable; the source is a correction notice.

          The notice provides no treatment or prescribing information.

          Clinical Best Practices

            Related Resources & Content

            Original Source(s)

            Related Content